ESBL, MBL and Ampc β lactamases producing superbugs - Havoc in the intensive care units of Punjab India

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 1, 2013, Pages 70-73

  Oberoi, Loveena ^a   Singh, Nachhatarjit ^a   Sharma, Poonam ^a   Aggarwal, Aruna ^a  

^a SRI GURU RAM DAS INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

AmpC lactamases; Antibiotic resistance; Extended spectrum lactamases (ESBLs); Intensive care units (ICUs); Metallo lactamases (MBLs)

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CITROBACTER; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS; PSEUDOMONAS;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 84872126851     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/5016.2673     Document Type: Article

References (20)

1. Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB. The metallo D lactamase producing clinical isolates from the patients of a tertiary care hospital. Journal of Laboratory Physicians.2011;3(2):93-97.
2. Khan MKR, Thukral SS, Gaind R. Evaluation of the modified double-isc synergy test for the detection of ESBLs in the Amp-C β lactamase-producing Proteus mirabilis. Ind J Med Microbial. 2008;26(1):58-61.
3. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64:29-36.
4. Khan MKR, Thukral SS, Gaind R. Evaluation of the modified doubleisc synergy test for the detection of ESBLs in the Amp-C β lactamaseproducing Proteus mirabilis. Ind J Med Microbial. 2008;26(1):58-61.
5. Pitout JD, Reisbig MD, Venter EC, Church DL, Hanson ND. Modification of the double disc test for the detection of the Enterobacteriaceae which produced the extended spectrum and the Amp-c wwlactamases. J Clin microbial. 2003;41:3933-35.
6. CLSI. The performance standards for the antimicrobial disc susceptibility tests. CLSI; Wayne PA; 2005; M100-S15.
7. Shahid S, Malik A, Agrawal M, Singhal S. The phenotypic detection of the extended spectrum and the AmpC ttlactamases by a new spot inoculation method and a modified three dimensional extract test. J Antimicrobial Chemother. 2004;54:684-87.
8. Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. The detection of Pseudomonas aeruginosa which produced metallo-oolactamases in a large centralized laboratory. J Clin Microbiol. 2005;43:3129-35.
9. Itokazu G, Quinn J, Bell-Dixon C, Kahan F, Weinstein R. The antimicrobial resistance rates among aerobic the gram-negative bacilli which were recovered from the patients in the intensive care units: the evaluation of a national postmarketing surveillance program. Clin Infect Dis. 1996;23:779-84.
10. Mary VJ, Kandathi AJ, Balaji V. Comparison of the methods for the detection of the carbapenamase and the metallo-lllactamases production in the clinical isolates. Ind. J. Med. Res.2005;121:780-83.
11. Mathur P, Kapil A, Das B, Dhawan B. The prevalence of ESBL producing gram negative bacteria in a tertiary care hospital. Ind J Med Res. 2002;115:153-57.
12. Kumar MS, Lakshmi V, Rajagopalan R. The occurrence of extended spectrum sslactamases among the Enterobacteriaceae species which were isolated at a tertiary care institute. Ind J Med Microbiol. 2006;24;208-11.
13. Bandekar N, Vinodkumar CS, Basavarajappa KG, Prabhakar PJ, Nagaraj P. The beta lactamases mediated resistance amongst the gram negative bacilli in burn infections. Int J of Bio Res.2011;2:766-70.
14. Harakuni S, Karadesai SG, Mutnal MB, Metgud SC. The prevalence of the extended spectrum-lactamase-producing clinical isolates of Klebsiella pneumoniae in the intensive care unit patients of a tertiary care hospital. Annals of tropical medicine and health 2011;4:96-98.
15. Laghawe A, Jaitly N, Thombare V. The simultaneous detection of the ESBL and the AmpC b-lactamases in gram negative bacilli. JCDR.2012;6:660-63.
16. Arora S, Bal M. The AmpC A-lactamase producing bacterial isolates at a Kolkata hospital. Ind J Med Res. 2005;122:224-33.
17. Bhattacharjee A, Anupurba S, Guar A, Sen MR. The prevalence of inducible AmpC i-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital in northern India, IJMM 2008;26:89-98.
18. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. The epidemiological investigation of the fl uroquinilone resistance in the infections which were caused by extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2001; 33:1288-94.
19. Subha A, Ananthan S, Alavandi SV. Extended spectrum beta lactamase production and multidrug resistance in the Klebsiella species which were isolated from children who were under fi ve years, who had intestinal and extra intestinal infections. Indian J Med Res. 2001; 113:181-85.
20. Laxmi V. The need for national/regional guidelines and policies in India to combat antibiotic resistance. Ind J Med Microbiol. 2008;26:105-07.